These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 29800797

  • 1. The impact of age on radium-223 distribution and an evaluation of molecular imaging surrogates.
    Jiang W, Ulmert D, Simons BW, Abou DS, Thorek DLJ.
    Nucl Med Biol; 2018; 62-63():1-8. PubMed ID: 29800797
    [Abstract] [Full Text] [Related]

  • 2. Sodium Fluoride-18 and Radium-223 Dichloride Uptake Colocalize in Osteoblastic Mouse Xenograft Tumors.
    Phelps TE, Roy J, Green MV, Seidel J, Baidoo KE, Adler S, Edmondson EF, Butcher D, Matta JL, Ton AT, Wong K, Huang S, Ren L, LeBlanc AK, Choyke PL, Jagoda EM.
    Cancer Biother Radiopharm; 2021 Mar; 36(2):133-142. PubMed ID: 33646017
    [Abstract] [Full Text] [Related]

  • 3. Radiotoxicity of alpha particles versus high and low energy electrons in hypoxic cancer cells.
    Maucksch U, Runge R, Oehme L, Kotzerke J, Freudenberg R.
    Nuklearmedizin; 2018 Apr; 57(2):56-63. PubMed ID: 29590676
    [Abstract] [Full Text] [Related]

  • 4. Preclinical Single Photon Emission Computed Tomography of Alpha Particle-Emitting Radium-223.
    Abou DS, Rittenbach A, Tomlinson RE, Finley PA, Tsui B, Simons BW, Jha AK, Ulmert D, Riddle RC, Thorek DLJ.
    Cancer Biother Radiopharm; 2020 Sep; 35(7):520-529. PubMed ID: 32182119
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Dosimetry of bone metastases in targeted radionuclide therapy with alpha-emitting (223)Ra-dichloride.
    Pacilio M, Ventroni G, De Vincentis G, Cassano B, Pellegrini R, Di Castro E, Frantellizzi V, Follacchio GA, Garkavaya T, Lorenzon L, Ialongo P, Pani R, Mango L.
    Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):21-33. PubMed ID: 26266887
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Targeting of osseous sites with alpha-emitting 223Ra: comparison with the beta-emitter 89Sr in mice.
    Henriksen G, Fisher DR, Roeske JC, Bruland ØS, Larsen RH.
    J Nucl Med; 2003 Feb; 44(2):252-9. PubMed ID: 12571218
    [Abstract] [Full Text] [Related]

  • 19. Comparing absorbed doses and radiation risk of the α-emitting bone-seekers [223Ra]RaCl2 and [224Ra]RaCl2.
    Lassmann M, Eberlein U.
    Front Med (Lausanne); 2022 Feb; 9():1057373. PubMed ID: 36687439
    [Abstract] [Full Text] [Related]

  • 20. Radium-223 dichloride in prostate cancer: proof of principle for the use of targeted alpha treatment in clinical practice.
    Dizdarevic S, McCready R, Vinjamuri S.
    Eur J Nucl Med Mol Imaging; 2020 Jan; 47(1):192-217. PubMed ID: 31471713
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.